conversion chart tirzepatide dosing for weight loss Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). educational comparison only—these are Switching from semaglutide to tirzepatide

This eliminates one of the most common sources of dosing errors in compounded tirzepatide, which is patients miscalculating draw volumes when concentrations change

It should be noted that higher dosages of vitamin B12 may be necessary when treating this population

POPULAR WEIGHT-LOSS MEDICATIONS LINKED TO HIDDEN SIDE EFFECTS, STUDY FINDS Individuals carrying one copy of this variant lost an average of 1.6 pounds more than those without it, according to the findings

The New England Journal of Medicine study found that while participants did lose muscle mass, the proportion of lean body mass to total body mass actually increased

PMID 36232607